DISEASE INDICATIONS: Cystic Fibrosis

MANUFACTURER: Vertex Pharmaceuticals Incorporated

USAGE: Oral

MEDICINE APPROVED BY:

Food and Drug Administration (FDA)

Trikafta (elexacaftor/tezacaftor/ivacaftor) is a medication used to treat cystic fibrosis in patients aged 12 years and older who have at least one F508del mutation in the CFTR gene.